European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients

AstraZeneca

Status: Completed

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

Study type: Observational

Funder types: Industry

Identifiers

NCT00722267

NIS-REU-DUM-2007/1

Details and patient eligibility

About

This study is investigating how patients with severe stable state COPD perceive the variability of their symptoms throughout the day, the week and the year; the impact of these variations on their daily activities or sleep quality and how they deal with their treatments. For this purpose patients will be asked to answer a questionnaire over the phone

Enrollment: 7,400 estimated patients

Sex: All

Ages: 45+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Outpatients with a diagnosis of COPD
• FEV1<50% and FEV1/FVC<0.7 according to lung function data in medical records.
• Smoker or ex-smoker > 10 pack-years
• Informed consent obtained

Exclusion criteria

• Ongoing exacerbation of COPD or within the previous 3 months
• Any other significant respiratory disease (including asthma and allergic rhinitis)